# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Benjamin Franklin (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN004-SYN-TD
- Date: 1782-03-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lydia Penhallow, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for primary care visit for recurrent gout flares and painful, interrupted urination with blood in the urine. **S**

## Objective

Serum urate: 9.1 mg/dL (high); Sodium: 140 mmol/L; Potassium: 4.1 mmol/L; Bicarbonate (total CO2): 25 mmol/L; BUN: 22 mg/dL; Creatinine: 1.36 mg/dL (high); eGFR: 54 mL/min/1.73 m² (low); Glucose: 98 mg/dL; Calcium: 9.5 mg/dL; Phosphate: 3.4 mg/dL; Intact PTH: 52 pg/mL; 25-hydroxyvitamin D: 34 ng/mL; Hemoglobin: 14.2 g/dL; ALT: 24 U/L; LDL cholesterol: 128 mg/dL (high); HbA1c: 5.6%; Urine albumin-creatinine ratio: 18 mg/g; Urine pH: 5.2 [pH]; Urine red cells: 12 /[HPF] (high); Blood lead: 3.1 ug/dL; IPSS: 16; KFRE 2-year kidney failure risk: 0.2%; KFRE 5-year kidney failure risk: 0.6%. All results are synthetic.

BP 148/86 mmHg; pulse 74 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 96 kg; BMI 31.3 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Gout with recurrent flares, mostly in the right big toe, without tophi; synthetic modern diagnosis linked to his documented gout; Chronic kidney disease stage G3a A1; Essential hypertension. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Stopped: Hydrochlorothiazide 25 mg oral tablet, one tablet by mouth daily **S**
- Started: Losartan 50 mg oral tablet, one tablet by mouth daily **S**
- Started: Allopurinol 100 mg oral tablet, one tablet by mouth daily **S**
- Started: Colchicine 0.6 mg oral tablet, one tablet by mouth daily for flare prophylaxis **S**
- Started: Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain, no more than 3 g a day **S**

## Plan

- Start allopurinol 100 mg daily and raise it by 100 mg every 2 to 5 weeks until serum urate is below 6 mg/dL; HLA-B*58:01 testing is not indicated, because he is not of Southeast Asian or African ancestry. Guideline: 2020 American College of Rheumatology Guideline for the Management of Gout (2020) **S**
- Colchicine 0.6 mg daily for three to six months as flare prophylaxis; treat flares with a short prednisone course or extra colchicine, and avoid NSAIDs because of chronic kidney disease. Guideline: 2020 American College of Rheumatology Guideline for the Management of Gout (2020); CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, and benign prostatic hyperplasia monographs (2026) **S**
- Replace hydrochlorothiazide with losartan, which lowers blood pressure and slightly lowers urate; check potassium and creatinine 2 to 4 weeks after starting. Guideline: 2020 American College of Rheumatology Guideline for the Management of Gout (2020); 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017); CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, and benign prostatic hyperplasia monographs (2026) **S**
- Urology referral to confirm and remove the bladder stone, look for bladder outlet obstruction and other causes of hematuria, and advise on stone prevention. Guideline: Medical Management of Kidney Stones: AUA Guideline (2014, amended 2019); EAU Guidelines on Urolithiasis (including bladder stones) (2025); Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2023 amendment) **S**
- CMID kidney and blood pressure monitoring: blood pressure every visit; eGFR and urine albumin yearly at G3a A1; calcium, phosphate, and PTH at baseline; hemoglobin and the kidney failure risk equation yearly; statin for age over 50 with eGFR below 60; medication review for NSAIDs every visit. Guideline: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, and benign prostatic hyperplasia monographs (2026) **S**
- Limit alcohol, especially beer and spirits, and purine-rich meat, organ meat, and shellfish; avoid sugar-sweetened drinks; aim for gradual weight loss and daily walking. Guideline: 2020 American College of Rheumatology Guideline for the Management of Gout (2020) **S**
